Status
Conditions
Treatments
About
Older women (≥65 years) with HR+ non-metastatic breast cancer experience high symptom burden and reduced quality of life during aromatase inhibitor (AI) therapy. This hierarchical 2×2 factorial randomized controlled trial will test two interventions: (1) a clinic-level geriatric oncology assessment and support program (GOAL-AI) and (2) a patient-level CBT-based coping skills training (CST-AI). The study aims to improve pain, symptom burden, and health-related quality of life compared to enhanced usual care.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
452 participants in 4 patient groups
Loading...
Central trial contact
Michael W Willis, BA; Smrithi Divakaran, MBBS, MSPH
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal